Literature DB >> 27584570

Remote Ischemic Preconditioning: A Novel Strategy in Rescuing Older Livers From Ischemia-reperfusion Injury in a Rodent Model.

Perparim Limani1, Michael Linecker, Christian E Oberkofler, Gery Barmettler, Andres Kaech, Rolf Graf, Bostjan Humar, Pierre-Alain Clavien.   

Abstract

OBJECTIVES: The aim of this study was to determine whether remote ischemic preconditioning (RIPC) protects aged liver against ischemia reperfusion (IR). SUMMARY OF BACKGROUND DATA: The demands for liver surgery in an aging population are growing. Clamping of vessels to prevent blood loss is integral to liver surgery, but the resulting IR injury (IRI) augments postoperative complications. More so, sensitivity to hepatic IRI increases with age; however, no strategies have been developed that specifically protect old liver. RIPC, a novel protective approach, was performed distant to the surgical site. Whether RIPC may also protect old liver from IRI is unknown.
METHODS: RIPC to the femoral vascular bundle was compared against direct ischemic preconditioning (IPC) and the standard of care intermittent clamping (IC) using a model of partial hepatic ischemia in mice aged 20 to 24 months. Liver injury was measured 6 hours after reperfusion. Protective signaling (serotonin-Vegf-Il10/Mmp8 axis, Kupffer cell polarization) was assessed immediately after preconditioning. Neutralizing antibody was used to test the role of Vegf. Hepatic vasculature was examined by electron microscopy.
RESULTS: RIPC was superior over other strategies in protecting old liver from IRI, with standard IPC approaches being ineffective. RIPC induced the strongest elevations in circulating Vegf, and Vegf inhibition dampened protective signaling and abrogated the protective effects. RIPC was further associated with improvements in vascular functionality.
CONCLUSIONS: RIPC is highly effective in protecting old liver from ischemic insults, mainly owing to its ability to induce circulating Vegf. These findings warrant efforts toward clinical translation.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27584570     DOI: 10.1097/SLA.0000000000001765

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  6 in total

1.  Endothelial cell-derived exosomes protect SH-SY5Y nerve cells against ischemia/reperfusion injury.

Authors:  Bing Xiao; Yi Chai; Shigang Lv; Minhua Ye; Miaojing Wu; Liyuan Xie; Yanghua Fan; Xingen Zhu; Ziyun Gao
Journal:  Int J Mol Med       Date:  2017-08-23       Impact factor: 4.101

Review 2.  The Janus Face of VEGF in Stroke.

Authors:  Samuel J Geiseler; Cecilie Morland
Journal:  Int J Mol Sci       Date:  2018-05-04       Impact factor: 5.923

Review 3.  Therapeutic strategies for ischemia reperfusion injury in emergency medicine.

Authors:  Hiromichi Naito; Tsuyoshi Nojima; Noritomo Fujisaki; Kohei Tsukahara; Hirotsugu Yamamoto; Taihei Yamada; Toshiyuki Aokage; Tetsuya Yumoto; Takaaki Osako; Atsunori Nakao
Journal:  Acute Med Surg       Date:  2020-04-13

Review 4.  Effects of Remote Ischemic Conditioning on Cerebral Hemodynamics in Ischemic Stroke.

Authors:  Chen Qin; Xiuli Yan; Hang Jin; Ruyi Zhang; Yaode He; Xin Sun; Yihe Zhang; Zhen-Ni Guo; Yi Yang
Journal:  Neuropsychiatr Dis Treat       Date:  2020-01-23       Impact factor: 2.570

5.  HMGB1 Protects the Heart Against Ischemia-Reperfusion Injury via PI3K/AkT Pathway-Mediated Upregulation of VEGF Expression.

Authors:  Yan-Hong Zhou; Qian-Feng Han; Lei Gao; Ying Sun; Zhan-Wei Tang; Meng Wang; Wei Wang; Heng-Chen Yao
Journal:  Front Physiol       Date:  2020-01-29       Impact factor: 4.566

6.  EP4 activation ameliorates liver ischemia/reperfusion injury via ERK1/2‑GSK3β‑dependent MPTP inhibition.

Authors:  Lin-Lin Cai; Hai-Tao Xu; Qi-Long Wang; Ya-Qing Zhang; Wei Chen; Dong-Yu Zheng; Fang Liu; Hong-Bin Yuan; Yong-Hua Li; Hai-Long Fu
Journal:  Int J Mol Med       Date:  2020-03-17       Impact factor: 4.101

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.